Arkolith/Insider Trading/ARMP

ARMP Insider Trading

Armata Pharmaceuticals, Inc. · full profile →Last filing Jul 10, 2026

Armata Pharmaceuticals, Inc. also files under APHB, TGEN.PK, TGEN; those filings are included.

Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
Jul 10, 2026Birx DeborahChief Executive Officer, DirectorTax withholding(F)14K$4.26$60K
Apr 24, 2026Gilmer Daniel B.DirectorGrant(A)51K—$0
Mar 14, 2026Birx DeborahChief Executive Officer, DirectorTax withholding(F)5K$10.54$52K
Mar 14, 2026Kyme PierreChief Business OfficerTax withholding(F)1K$10.54$11K
Mar 9, 2026Peterson Todd C.DirectorGrant(A)26K—$0
Mar 9, 2026Patti Joseph MDirectorGrant(A)26K—$0
Mar 9, 2026House David DuaneSVP, Finance, and PFOGrant(A)110K—$0
Mar 9, 2026Kramer RobinDirectorGrant(A)26K—$0
Mar 9, 2026Schlesinger Sarah J.DirectorGrant(A)26K—$0
Mar 9, 2026Odysseas Kostas DDirectorGrant(A)26K—$0
Mar 9, 2026Birx DeborahChief Executive Officer, DirectorGrant(A)421K—$0
Mar 9, 2026Kyme PierreChief Business OfficerGrant(A)183K—$0
Mar 9, 2026Haimovitz JulesDirectorGrant(A)26K—$0
Jul 10, 2025Birx DeborahChief Executive Officer, DirectorTax withholding(F)14K$2.27$31K
Mar 14, 2025Kyme PierreChief Business OfficerTax withholding(F)1K$1.95$2K
Mar 14, 2025Birx DeborahChief Executive Officer, DirectorTax withholding(F)6K$1.95$12K
Feb 5, 2025House David DuaneSVP, Finance, and PFOGrant(A)25K—$0
Feb 5, 2025Patti Joseph MDirectorGrant(A)54K—$0
Feb 5, 2025Kramer RobinDirectorGrant(A)54K—$0
Feb 5, 2025Birx DeborahChief Executive Officer, DirectorGrant(A)240K—$0
Feb 5, 2025Peterson Todd C.DirectorGrant(A)54K—$0
Feb 5, 2025Odysseas Kostas DDirectorGrant(A)54K—$0
Feb 5, 2025Schlesinger Sarah J.DirectorGrant(A)54K—$0
Feb 5, 2025Kyme PierreChief Business OfficerGrant(A)100K—$0
Feb 5, 2025Haimovitz JulesDirectorGrant(A)54K—$0
Oct 2, 2024House David DuaneSVP, Finance, and PFOGrant(A)75K—$0
Jul 10, 2024Birx DeborahChief Executive Officer, DirectorTax withholding(F)23K$2.68$61K
Mar 14, 2024Kramer RobinDirectorGrant(A)54K—$0
Mar 14, 2024Kramer RobinDirectorGrant(A)40K—$0
Mar 14, 2024Patti Joseph MDirectorGrant(A)40K—$0
Mar 14, 2024Rychlik RichardCorporate Controller and PFOGrant(A)40K—$0
Mar 14, 2024Schlesinger Sarah J.DirectorGrant(A)54K—$0
Mar 14, 2024Schlesinger Sarah J.DirectorGrant(A)40K—$0
Mar 14, 2024Patti Joseph MDirectorGrant(A)54K—$0
Mar 14, 2024Peterson Todd C.DirectorGrant(A)40K—$0
Mar 14, 2024Haimovitz JulesDirectorGrant(A)54K—$0
Mar 14, 2024Odysseas Kostas DDirectorGrant(A)40K—$0
Mar 14, 2024Rychlik RichardCorporate Controller and PFOGrant(A)10K—$0
Mar 14, 2024Haimovitz JulesDirectorGrant(A)40K—$0
Mar 14, 2024Birx DeborahChief Executive Officer, DirectorGrant(A)60K—$0
Mar 14, 2024Peterson Todd C.DirectorGrant(A)54K—$0
Mar 14, 2024Odysseas Kostas DDirectorGrant(A)54K—$0
Mar 14, 2024Birx DeborahChief Executive Officer, DirectorGrant(A)240K—$0
Dec 21, 2023Schlesinger Sarah J.DirectorGrant(A)10K—$0
Dec 21, 2023Kramer RobinDirectorGrant(A)10K—$0
Dec 21, 2023Patti Joseph MDirectorGrant(A)10K—$0
Dec 21, 2023Rychlik RichardCorporate Controller and PFOGrant(A)50K—$0
Dec 21, 2023Birx DeborahChief Executive Officer, DirectorGrant(A)200K—$0
Dec 21, 2023Birx DeborahChief Executive Officer, DirectorGrant(A)200K—$0
Dec 21, 2023Odysseas Kostas DDirectorGrant(A)10K—$0
Dec 21, 2023Haimovitz JulesDirectorGrant(A)10K—$0
Dec 21, 2023Peterson Todd C.DirectorGrant(A)10K—$0
Jan 10, 2023Innoviva Strategic Opportunities LLCDirector, 10% OwnerBuy(P)0$30,000,000.00as filed—
Apr 13, 2022Haimovitz JulesDirectorGrant(A)33K—$0
Apr 13, 2022Morris Duane AlfredVP of OperationsGrant(A)41K—$0
Apr 13, 2022Varnum BrianPresident and CEOGrant(A)240K—$0
Apr 13, 2022Patrick ToddDirectorGrant(A)33K—$0
Apr 13, 2022Patti Joseph MDirectorGrant(A)33K—$0
Apr 13, 2022Peterson Todd C.DirectorGrant(A)33K—$0
Apr 13, 2022Kramer RobinDirectorGrant(A)33K—$0
Apr 13, 2022Odysseas Kostas DDirectorGrant(A)33K—$0
Apr 13, 2022Schlesinger Sarah J.DirectorGrant(A)33K—$0
Mar 31, 2022Innoviva, Inc.Director, 10% OwnerBuy(P)0$5.00$0
Mar 31, 2022Innoviva, Inc.Director, 10% OwnerBuy(P)5.4M$5.00$26.9M
Feb 9, 2022Innoviva Strategic Opportunities LLCDirector, 10% OwnerBuy(P)1.8M$5.00$9.0M
Feb 9, 2022Innoviva Strategic Opportunities LLCDirector, 10% OwnerBuy(P)3.6M$5.00$18.1M
Oct 29, 2021Innoviva Strategic Opportunities LLCDirector, 10% OwnerBuy(P)1.2M$3.30$4.0M
Aug 2, 2021Varnum BrianCEO, DirectorGrant(A)125K—$0
Jun 7, 2021Schlesinger Sarah J.DirectorGrant(A)28K—$0
Jun 7, 2021Peterson Todd C.DirectorGrant(A)28K—$0
Jun 7, 2021Patti Joseph MDirectorGrant(A)28K—$0
Jun 7, 2021Kramer RobinDirectorGrant(A)28K—$0
Jun 7, 2021Odysseas Kostas DDirectorGrant(A)28K—$0
Apr 1, 2021Haimovitz JulesDirectorGrant(A)30K—$0
Mar 25, 2021Patrick ToddChief Executive Officer, DirectorGrant(A)112K—$0
Mar 25, 2021Varnum BrianPresident and CDOGrant(A)112K—$0
Mar 25, 2021Morris Duane AlfredVP of OperationsGrant(A)28K—$0
Mar 25, 2021Martin Steven RobertChief Financial OfficerGrant(A)56K—$0
Mar 17, 2021Innoviva, Inc.Director, 10% OwnerBuy(P)4.3M$3.25$13.9M
Mar 17, 2021Innoviva, Inc.Director, 10% OwnerBuy(P)4.3M$3.25$13.9M
Jan 26, 2021Innoviva Strategic Opportunities LLCDirector, 10% OwnerBuy(P)1.9M$3.25$6.1M
Jan 26, 2021Innoviva Strategic Opportunities LLCDirector, 10% OwnerBuy(P)1.9M$3.25$6.1M
Dec 8, 2020Patti Joseph MDirectorGrant(A)23K—$0
Dec 8, 2020Peterson Todd C.DirectorGrant(A)23K—$0
Dec 8, 2020Morris Duane AlfredVP of OperationsGrant(A)23K—$0
Dec 8, 2020Kramer RobinDirectorGrant(A)30K—$0
Dec 8, 2020Martin Steven RobertChief Financial OfficerGrant(A)23K—$0
Dec 8, 2020Varnum BrianPresident and CDOGrant(A)23K—$0
Dec 8, 2020Bastiani RichardDirectorGrant(A)23K—$0
Dec 8, 2020Odysseas Kostas DDirectorGrant(A)23K—$0
Dec 8, 2020Schlesinger Sarah J.DirectorGrant(A)23K—$0
Dec 8, 2020Patrick ToddChief Executive Officer, DirectorGrant(A)23K—$0
Mar 27, 2020Innoviva, Inc.10% OwnerBuy(P)7.7M$2.87$22.1M
Mar 27, 2020Innoviva, Inc.10% OwnerBuy(P)7.7M$2.87$22.1M
Feb 12, 2020Schlesinger Sarah J.DirectorGrant(A)27K—$0
Feb 12, 2020Odysseas Kostas DDirectorGrant(A)27K—$0
Oct 10, 2019Peterson Todd C.DirectorGrant(A)27K—$0
May 22, 2019Varnum BrianPresident and CDOGrant(A)299K—$0
May 22, 2019Parker H StewartDirectorGrant(A)27K—$0
May 22, 2019Cook Jeremy CurnockDirectorGrant(A)27K—$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Issuer: Armata Pharmaceuticals, Inc., SEC CIK 0000921114. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under ARMP and shows every filing by that issuer (also filed as APHB, TGEN.PK, TGEN).

Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-11. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).

Keep exploring

Connected pages for ARMP